Global Patent Index - EP 1704416 A2

EP 1704416 A2 20060927 - PROTEIN EXPRESSION PROFILING AND BREAST CANCER PROGNOSIS

Title (en)

PROTEIN EXPRESSION PROFILING AND BREAST CANCER PROGNOSIS

Title (de)

ERSTELLUNG VON PROTEINEXPRESSIONSPROFILEN UND BRUSTKREBSPROGNOSE

Title (fr)

ETABLISSEMENT DE PROFILS D'EXPRESSION DE PROTEINES ET PROGNOSE DU CANCER DU SEIN

Publication

EP 1704416 A2 20060927 (EN)

Application

EP 05702409 A 20050117

Priority

  • IB 2005000261 W 20050117
  • US 53741204 P 20040116
  • US 3629805 A 20050114

Abstract (en)

[origin: WO2005071419A2] A method for analyzing differential protein expression associated with histopathologic features of breast disease comprising the detection of the overexpression or underexpression of a pool of proteins in breast tissues or cells, said pool comprising all or part, for example one, two, three or more of a protein set comprising: Afadin, Aurora A, a-Catenin, b-Catenin, BCL2, Cyclin Dl, Cyclin E, Cytokeratin 5/6, Cytokeratin 8/18, E-Cadherin, EGFR, ERBB2, ERBB3, ERBB4, Estrogen receptor, FGFR1, FHIT, GATA3, Ki67, Mucin 1, P53, P-Cadherin, Progesterone receptor, TACC1, TACC2, TACC3, Cytokeratin 6, Cytokeratin 18, Angl, AuroraB, BCRP1, CathepsinD, CD10, CD44, CK14, Cox2, FGF2, GATA4, Hifla, MMP9, MTA1, NM23, NRG1a, NRGlbeta, P27, Parkin, PLAU, S100, SCRIBBLE, Smooth Muscle Actin, THBS1, TIMP1.

IPC 8 full level

G01N 33/574 (2006.01)

CPC (source: EP)

G01N 33/57415 (2013.01); G01N 2333/4739 (2013.01); G01N 2333/4742 (2013.01); G01N 2333/705 (2013.01); G01N 2333/70567 (2013.01); G01N 2333/71 (2013.01); G01N 2333/96466 (2013.01)

Citation (search report)

See references of WO 2005071419A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2005071419 A2 20050804; WO 2005071419 A3 20060223; EP 1704416 A2 20060927

DOCDB simple family (application)

IB 2005000261 W 20050117; EP 05702409 A 20050117